xueling Liu1, Pu-Yeh Wu2, and Yuxin Li1
1Department of Radiology, Huashan hospital affiliated to Fudan University, Shanghai, China, 2GE Healthcare, Beijing, China, Shang Hai, China
Synopsis
In
this study, we investigated alterations of iron and NM in EPD, and correlations
between them and VMAT2 binding in nigrostriatal system. Our results suggested
that changes of neuromelanin and susceptibility on QSM images could
quantitatively reflect the pathology of EPD and could be used as imaging
biomarkers for diagnosing of EPD. The SUR measured by 18F-DTBZ
images could reflect the lateralization in EPD patients. NM volume could
reflect the striatal dopaminergic function, and both CR value and SUR could
reflect the severity of motor impairment in EPD, which are expected to be used
for monitoring the progression of EPD.
Introduction
Parkinson’s disease (PD) is
characterized by the progressive loss of neuromelanin (NM)-containing dopaminergic
neurons and iron deposition in the substantia nigra pars compacta (SNc)1,2.
The relationship among iron, NM and dopamine in PD is complicated3. Relationships
between iron deposition and NM, and between NM and dopamine uptake of have been extensively studied4-6.
However, no study investigated the association of iron deposition or NM with vesicular monoamine transporter 2 (VMAT2) uptake
expressed by 18F-9-fuloropropyl-(+)-dihydrotetrabenazine (18F-DTBZ).
In
this study, we aim to evaluate the changes of iron and NM in SNc in early
Parkinson’s disease (EPD), and to detect the correlations between them and VMAT2
binding in nigrostriatal system, as well as the associations of these measures
with clinical symptoms.
Materials
and Methods
Data from 29 PD patients at early stage of disease (H&Y
stage ≤ 2) and
46 age- and gender-matched healthy controls (HCs) were prospectively collected
in Huashan Hospital affiliated to Fudan University from September 2017 to
December 2019. All participants underwent MRI examinations including quantitative
susceptibility mapping (QSM) and 3D T1WI on a 3T scanner (DiscoveryTM MR750, GE
Healthcare, Milwaukee, WI). EPD patients also underwent 18F-DTBZ
scan. Short-echo-time magnitude (setMag) and susceptibility images were
reconstructed from QSM. After co-registration of setMag, susceptibility and 18F-DTBZ
images to T1WI images using FMRIB Software Library (FSL; http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL), we manually segmented ROIs
of bilateral SNc on setMag images. The ROIs of bilateral putamen and caudate
were auto-segmented using FSL on T1WI images and ROI in occipital lobe was
manually delineated on 18F-DTBZ images. On setMag images, the NM
volume was measured and contrast ratio (CR) was calculated with cerebral
peduncle as the reference. The susceptibility value was measured on
susceptibility images. The specific uptake ratio (SUR) was calculated according
to the formula (specific uptake / occipital lobe uptake) - 1. The EPD patients
were divided into contralateral and ipsilateral part according to the
difference > |1|
in left and right side of UPDRSIII score. The UPDRSIII score was subdivided
into tremor, posture and gait, and bradykinesia. One-way ANOVA was used to
compare the differences of NM volume, CR and susceptibility values among HC,
contralateral and ipsilateral EPD patients, and post-hoc analysis was used to assess
the difference between contralateral and ipsilateral part of EPD. Paired t-test
was used to compare the SUR difference between contralateral and ipsilateral
part of EPD. Associations of NM volume, CR, susceptibility values, SURs and
clinical symptoms were investigated by partial correlation analysis while controlling
for age and gender.
Results
Compared
with the HC group, the NM volumes in SNc of the contralateral and ipsilateral
part of EPD patients were both decreased (152 ± 23.43 vs 103.9 ± 27.34 and
117.7 ± 26.93 mm3, p < 0.0001), CR values were both lower (0.32 ±
0.05 vs 0.26 ± 0.08 and 0.27 ± 0.06, p < 0.0001) and the susceptibility
values were both higher (0.08 ± 0.02 vs 0.10 ± 0.01 and 0.10 ± 0.02 ppm, p <
0.0001) (Figure 1). There was no significant difference in NM volume, CR
or susceptibility value in SNc between the contralateral and ipsilateral part
of EPD patients. The SURs of contralateral SNc (0.25 ± 0.14 vs 0.29 ± 0.13, p =
0.044), putamen (0.67 ± 0.32 vs 0.84 ± 0.33, p < 0.0001) and caudate (0.74 ±
0.31 vs 0.87 ± 0.31, p < 0.0001) were all significantly lower than the
ipsilateral side in EPD. There were negative correlations between
susceptibility and CR value in HC (r = -0.38, p = 0.01), and in contralateral
part of EPD (r = -0.44, p = 0.02) (Figure 2). In the contralateral part
of EPD, there were positive correlations between NM volume and SUR in putamen (r
= 0.58, p = 0.002) and in caudate (r = 0.49, p = 0.009), while in the
ipsilateral part of EPD, the positive correlation was only found between NM
volume and SUR in caudate (r = 0.39, p = 0.04) (Figure 3). The mean SUR
of bilateral SNc was negatively correlated with the UPDRSIII score (r = -0.56, p
= 0.003). The mean SUR of bilateral SNc, putamen and caudate were all
negatively correlated with the score of posture and gait (SNc: r = -0.44, p =
0.02; putamen: r = -0.47, p = 0.01; caudate: r = -0.44, p = 0.02), and
bradykinesia (SNc: r = -0.55, p = 0.003; putamen: r = -0.39, p = 0.04; caudate:
r = -0.46, p = 0.02). The mean CR value was also negatively correlated with the
score of posture and gait (r = -0.44, p = 0.02).
Conclusion
Changes
of neuromelanin and susceptibility on QSM images could quantitatively reflect
the pathology of EPD and could be used as imaging biomarkers for diagnosing of
EPD. The SUR measured by 18F-DTBZ images could reflect the
lateralization in EPD patients. NM volume could reflect the striatal
dopaminergic function, and both CR value and SUR could reflect the severity of
motor impairment in EPD, which are expected to be used for monitoring the
progression of EPD.Acknowledgements
No acknowledgement found.References
1. Ward RJ, Zucca FA, Duyn JH, et
al. The role of iron in brain ageing and neurodegenerative disorders[J]. The
Lancet Neurology, 2014, 13(10): 1045-1060.
2. Damier P, Hirsch EC, Agid Y, et
al. The substantia nigra of the human brain. II. Patterns of loss of
dopamine-containing neurons in Parkinson's disease[J]. Brain : a journal of
neurology, 1999, 122 ( Pt 8): 1437-1448.
3. Zucca FA, Segura-Aguilar J,
Ferrari E, et al. Interactions of iron, dopamine and neuromelanin pathways in
brain aging and Parkinson's disease[J]. Prog Neurobiol, 2017, 155: 96-119.
4. Ito H, Kawaguchi H, Kodaka F, et
al. Normative data of dopaminergic neurotransmission functions in substantia
nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine
transporters, and dopamine D2 receptors[J]. Neuroimage, 2017, 158: 12-17.
5. Martin-Bastida A, Lao-Kaim NP,
Roussakis AA, et al. Relationship between neuromelanin and dopamine terminals
within the Parkinson's nigrostriatal system[J]. Brain : a journal of neurology,
2019, 142(7): 2023-2036.
6.
Kuya K, Ogawa T, Shinohara Y, et al. Evaluation of Parkinson's disease by
neuromelanin-sensitive magnetic resonance imaging and (123)I-FP-CIT SPECT[J].
Acta Radiol, 2018, 59(5): 593-598.